PXS 39c only $120m, cash possible $91m at the moment ($62m on 31/12/12 + $40m from NovaQuest Pharma - $11m cash outflow for Mar 2013 quarter = $91m)
E/V is only around $29m. PXS is presenting good value at current price.
PXS 39c only $120m, cash possible $91m at the moment ($62m on...
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)